Australia's most trusted
source of pharma news
Tuesday, 23 April 2024
Posted 30 November 2021 AM
The bitter turf war between NSW and Victoria to become Australia's mRNA epicentre needs to end, according BioCina CEO Ian Wisenberg, who is calling for a national effort to establish an onshore, large scale mRNA manufacturing capability.
The east coast states have been jockeying for months to land a deal pledged by the federal government in May to establish a sovereign mRNA plant that can produce at scale.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.